Articles related to Family Medicine/General Practice
DermDx: Crusted, Bleeding Patch on Forehead
A 70-year-old woman with a skin lesion on her right temple is referred for assessment. She claims that the site originally came to light about a year ago and has grown in size ever since. An erythematous, fibrotic plaque with a depressed center is discovered during examination. What is the most likely cause of the lesion?
Dermatology September 20th 2022
MKSAP Quiz: Genetic Consult for Breast Cancer Risk
A 29-year-old woman bought a genetic test that includes BRCA analysis. She comes to you with the results and asks for guidance. The results are negative for BRCA1 and BRCA2, but she has a positive family history for breast cancer. What do you advise?
Family Medicine/General Practice September 20th 2022
Four Groundbreaking Clinical Studies Worth Your Attention
A quartet of current clinical trials involving first-in-class molecules and CRISPR gene editing show great promise. STELLAR investigates a fusion protein in PAH, CodeBreak 200 studies a first-in-class of KRAS inhibitor, EMERGENT-2 focuses on a new treatment for schizophrenia, and NCT04601051 studies a gene editing drug for one form of amyloidosis.
Cardiology September 20th 2022
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
In this cross-sectional study of US adults hospitalized with COVID-19 during January 2022 to April 2022, hospitalization rates from COVID were 10.5 times higher in unvaccinated persons and 2.5 times higher in vaccinated persons with no booster dose, respectively, compared with those who had received a booster dose.
Allergy & Immunology September 20th 2022
DEA: “Rainbow Fentanyl” a Deliberate Tactic to Target Young People
The colorful fentanyl, known as “rainbow fentanyl,” has been identified in 18 different states and has been found in a variety of forms, including pills, powder, and blocks that resemble sidewalk chalk, according to a press release from the agency. No particular color has been found to have a higher potency through testing. According to the DEA, every shade, shape, and size should be viewed as being exceedingly harmful.
Family Medicine/General Practice September 19th 2022